US Executive Compensation Proxy SEC Filings — October 20, 2026

20-10-2026

Benitec Biopharma Inc. filed its definitive DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on December 3, 2026 at 1:00 p.m. Pacific Time, with a record date of October 13, 2026. Stockholders will vote on three Class I director nominees, ratification of the independent registered public accounting firm for fiscal year ending June 30, 2027, and a non-binding say-on-pay advisory vote. As of the record date, 34,889,313 common shares were outstanding, excluding 14,604,643 shares underlying unexercised pre-funded warrants that carry no voting rights until exercised.

• · Notice of Internet Availability of Proxy Materials to be sent on or about October 23, 2026
• · Each common share carries one vote; cumulative voting is not permitted
• · Quorum requires a majority of outstanding shares on the record date; abstentions and broker non-votes count toward quorum
• · Unmarked signed proxies will be voted in favor of company proposals
• · Annual Report for fiscal year ended June 30, 2026 is available alongside the proxy materials
• · Company headquarters located at 3940 Trust Way, Hayward, California

20-10-2026

Alset Inc. (AEI) has filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, scheduled for December 3, 2026 at 9:00 A.M. Eastern Standard Time in a virtual format. Stockholders will vote on four items: the election of seven directors, ratification of HTL International, LLC as the independent registered public accounting firm for fiscal 2026, a non-binding say-on-pay vote on named executive officer compensation, and a non-binding say-on-frequency vote. The Board unanimously recommends voting FOR all proposals, including a three-year frequency for future say-on-pay votes.

• · Record date is October 5, 2026; Notice of Internet Availability to be mailed on or about October 19, 2026
• · Quorum requires presence of 35% of shares entitled to vote; abstentions and broker non-votes count toward quorum
• · Directors are elected by plurality; withheld votes and broker non-votes have no effect on outcome
• · Ratification of auditor requires majority of votes cast; routine matter allowing broker discretionary voting
• · Say-on-pay and say-on-frequency votes are non-binding but the Board will consider stockholder input
• · Chan Heng Fai reported 45 years of banking and finance experience and multiple concurrent board roles at subsidiaries and other listed companies, including chairmanship of EnerSyn Global Inc. through September 2026
• · No proxy solicitor engaged; solicitation handled by officers and employees at no additional compensation
• · Annual Report on Form 10-K for fiscal year ended December 31, 2025 accompanies the proxy materials but is not part of the solicitation materials

20-10-2026

Fabrinet has filed its definitive 2026 proxy statement for its virtual Annual General Meeting on December 10, 2026, seeking shareholder votes on two Class II director nominees, ratification of PricewaterhouseCoopers ABAS Ltd. as auditor for fiscal 2027, and a non-binding advisory vote on named executive officer compensation. The filing reports fiscal 2026 revenue of $4,641.1 million, up 35.7% YoY, and net income of $473.0 million, up 42.3% YoY, but GAAP gross margin edged down 10 basis points to 12.0% and non-GAAP gross margin fell 20 basis points to 12.2%.

• · Fiscal 2026 marked the sixth successive fiscal year of record revenue, net income, and net income per diluted share
• · Closing share price rose 59.4% from $285.23 to $454.55 following fiscal year-end results announcement
• · Operating margin improved to 10.0% from 9.5% and non-GAAP operating margin improved to 10.8% from 10.5%, despite lower gross margins
• · Annual Report on Form 10-K for fiscal year ended June 26, 2026 was filed with the SEC on August 18, 2026
• · Annual Meeting is virtual-only, with a fallback reconvening at 11:00 a.m. PST if technical issues affect quorum
• · Board attendance: incumbent directors attended 100% of Board and Committee meetings in fiscal 2026
• · Filing is classified as 'No fee required' for SEC filing purposes

20-10-2026

Copley Acquisition Corp (COPL-UN) has filed a definitive proxy statement for an extraordinary general meeting on October 29, 2026, seeking shareholder approval to extend its business combination deadline from November 2, 2026 up to 12 one-month extensions to November 2, 2027, funded by $150,000 per monthly extension deposited into the trust account as a non-interest bearing promissory note. The Trust account holds approximately $183.0 million, with a redemption price of about $10.61 per public share versus a NYSE closing price of $10.59, and the Board cautions that completion of a business combination within the extended period is not assured.

• · Extension Amendment requires a special resolution (two-thirds of votes cast by present/represented shares), and the Trust Agreement Amendment requires two-thirds of outstanding shares represented and voted.
• · Shareholders may redeem Public Shares regardless of how they vote; if the proposals fail, the company must redeem all Public Shares within 10 business days and dissolve.
• · Sponsor is not obligated to fund extensions, and warrants would expire worthless upon liquidation.
• · The Company may still choose not to exercise an extension and liquidate on the Termination Date even if the proposals are approved.
• · The existing charter allowed two three-month extensions (up to 24 months total), which the Extension Amendment would replace.

20-10-2026

CSLM Digital Asset Acquisition Corp III, Ltd (KOYNU) filed a definitive proxy statement dated October 19, 2026 for an Annual General Meeting on November 10, 2026, seeking shareholder approval to change its name to First Digital Acquisition Corp Ltd., amend its Articles accordingly, and approve a possible adjournment. The name change aligns the SPAC with First Digital Group Ltd., its target under a definitive Business Combination Agreement signed October 6, 2026, though shareholders are not voting on that combination at this time. The filing is administrative in nature and reports no operating financial results, so no sentiment is drawn from performance data.

• · Record Date is October 9, 2026; proxy materials first mailed on or about October 21, 2026
• · Voting deadline is 11:59 p.m. on November 6, 2026 (two business days before the meeting)
• · Name Change Proposal and Articles Amendment Proposal require a special resolution (at least two-thirds of votes cast); Adjournment Proposal requires an ordinary resolution (simple majority)
• · Articles Amendment Proposal is conditional on approval of the Name Change Proposal; otherwise the Third A&R M&A will not take effect
• · If approved, ticker symbols would change from KOYNU, KOYN and KOYNW to FDGXU, FDGX and FDGXW on Nasdaq
• · Shareholders are not voting on the Proposed Business Combination now and retain redemption rights for their Public Shares from the Trust Account if the combination is approved and consummated or if no combination occurs by the liquidation date
• · Directors are elected prior to closing only by Class B ordinary share holders; no directors are up for election at this meeting
• · Board unanimously recommends voting FOR all proposals; abstentions and broker non-votes will have no effect on outcomes under the stated voting rules
• · Filed with 'No fee required' and no annual report furnished under Rule 14a-3 because no directors are being elected

20-10-2026

Stellar V Capital Corp. (SVCCW), a Cayman Islands blank-check company, has filed a definitive proxy statement for an annual general meeting on October 29, 2026. Shareholders will vote on a special-resolution Extension Amendment that would extend the deadline for completing an initial business combination from October 31, 2026 to July 31, 2027, alongside the re-election of director Christopher Thomas, ratification of WithumSmith+Brown as auditor, and an adjournment proposal. No business combination is being voted on at this meeting.

• · Redemption requests and share tenders must be submitted by October 27, 2026, two business days before the meeting, with shares tendered via transfer agent or DTC DWAC.
• · If the Extension Amendment passes and the board cannot complete a combination by July 31, 2027, public shares will be redeemed within ten business days at trust value per share, with up to $100,000 available for dissolution expenses.
• · Initial Shareholders have agreed to waive redemption rights on founder shares and to waive liquidating distribution rights from the trust on founder shares if the combination is not completed on time.
• · The Record Date for voting is October 6, 2026.
• · The Adjournment Proposal will only be presented if there are insufficient votes for the Extension Amendment Proposal or the board deems adjournment in the company's best interests.

20-10-2026

Traws Pharma (TRAW) is asking stockholders to approve a reverse stock split at the Board's discretion within a 1-for-8 to 1-for-15 range, primarily to regain compliance with Nasdaq's $1.00 minimum bid price requirement after receiving a deficiency letter on July 29, 2026. The Company has until January 25, 2027 to regain compliance, and the stock closed at $0.59 on September 30, 2026. Management and the Board acknowledge negative perceptions of reverse splits and the historical tendency of such stock prices to revert, but determined that maintaining the Nasdaq listing outweighs these risks.

• · Board may set the split ratio anywhere from 1-for-8 to 1-for-15 and may abandon the split entirely, with authority expiring if not implemented within twelve months of stockholder approval.
• · Management expects to implement the Reverse Split shortly after stockholder approval; if stockholders reject it, the Company states its common stock could be delisted from Nasdaq.
• · The Reverse Split does not change authorized common or preferred share counts or par value, meaning authorized but unissued shares proportionally increase, which the filing notes could carry an anti-takeover effect.
• · The Board states it is not aware of any takeover attempt and that the Reverse Split is not part of any anti-takeover plan.
• · The Reverse Split is not intended as a Rule 13e-3 going-private transaction, and the Company will remain subject to Exchange Act periodic reporting.
• · The Company will receive a new CUSIP number after the split, and the ticker will remain TRAW if Nasdaq rules are met.
• · The Company is a smaller reporting company and has elected reduced executive compensation disclosure requirements.

20-10-2026

DSS, Inc. has filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held December 2, 2026 in West Henrietta, New York. Stockholders will vote on electing seven directors, ratifying HTL International, LLC as independent auditor for fiscal 2026 (estimated audit and review fees of $240,000 to $270,000), and an advisory vote on executive compensation. The Record Date is October 5, 2026, with 10,042,518 common shares outstanding and a 35% quorum requirement.

• · Director nominees require a majority of votes cast (more FOR than WITHHOLD votes) to be elected.
• · Auditor ratification and advisory say-on-pay require a majority of votes cast; both votes are non-binding for say-on-pay.
• · HTL International, LLC. PCAOB Auditor ID is 7000; representatives are not expected to attend the meeting.
• · Proxy materials are first being sent to stockholders on or around October 23, 2026, under the full set delivery option.
• · Abstentions and broker non-votes do not affect the outcome of votes on directors or auditor ratification; only auditor ratification is treated as a routine matter allowing broker discretionary voting.
• · Fees paid to former auditor Grassi & Co. fell from approximately $297,000 in 2024 to approximately $140,000 in 2025 (a decline of about 53%).
• · The audit committee pre-approved all services performed by HTL International, LLC.; the auditor's report for FY2025 contained no adverse opinion, disclaimer, or qualification.

20-10-2026

Theriva Biologics has filed a definitive proxy statement for a Special Meeting of Stockholders on November 18, 2026, seeking approval for three items: (1) an amendment increasing authorized common stock from 450,000,000 (already approved by stockholders in August 2026 but not yet filed) to 500,000,000 shares, at the Board's discretion; (2) ratification and, to the extent necessary, new approval of the issuance of up to 16,184,560 shares upon exercise of warrants issued to institutional investors in an October 17, 2025 private placement, following disclosure errors in the 2026 annual meeting proxy regarding NYSE routine/non-routine classification; and (3) adjournment if needed. The Board states that 450,000,000 authorized shares may be insufficient for future equity financings and strategic transactions, though no definitive commitments currently exist.

• · Record date for stockholder voting is October 9, 2026; meeting held at the company's Parets del Vallès (Barcelona, Spain) research and clinical development facility.
• · The 2026 Annual Meeting proxy contained errors inconsistently classifying the warrant proposal as routine vs. non-routine under NYSE rules, prompting the ratification request.
• · Under the 2026 vote standard (majority of shares present and entitled to vote), broker non-votes were not counted as entitled to vote on the warrant proposal.
• · The Board's authorized-share increase is contingent on stockholder approval and on the Board deciding to file the charter amendment within one year of approval.
• · Management states there are currently no definitive commitments for issuance of the additional shares contemplated by the increase.

20-10-2026

Greenbacker Renewable Energy Co LLC has filed a definitive proxy statement/prospectus (DEFM14A) dated October 20, 2026, seeking member approval for a merger with MN8 Energy Holdings LLC, to be voted on at a virtual annual meeting on November 23, 2026. The Aggregate Consideration Amount is set at $375,000,000 before adjustments for transaction expenses, a reserve amount, and a $25,000,000 Additional Consideration Holdback. The excerpt provided is largely front matter and table of contents, so the financial performance comparison and detailed merger economics are not available in this text.

• · Annual Meeting is a virtual meeting scheduled for November 23, 2026
• · Requests for proxy materials must be submitted by November 16, 2026 to be received before the meeting
• · Registration Statement on Form S-4 (No. 333-298194) was filed by MN8 with the SEC
• · Wells Fargo has provided a fairness opinion to Greenbacker's board (Annex F)
• · Merger consideration includes cash and stock election options subject to a Maximum Cash Election Amount and proration
• · Alternative Liquidity Event must occur within 12 months following the Liquidity Date for Legacy Members to sell MN8 Common Units
• · Specified Project change orders without MN8 consent reduce the Adjusted Additional Consideration Holdback Amount

20-10-2026

DeFi Capital Markets, Inc. (filing headed as Universal Safety Products, Inc. / UUU) has filed a DEF 14A proxy statement for a fully virtual annual meeting of stockholders, with a record date of October 20, 2026. The Board recommends voting FOR all six proposals, including election of two director nominees, ratification of CBIZ CPAs P.C. as auditor, amendments to the Articles to authorize 25 million shares each of black check preferred and class B common stock, approval of share issuances underlying convertible notes under an amended Securities Purchase Agreement dated October 9, 2026, and adjournment authority. The 3,028,463 outstanding shares set a quorum of 1,514,232 shares.

• · Annual Meeting begins 12:00 p.m. Eastern Time; legal proxy registration deadline is 5:00 p.m. Eastern Time on November 17, 2026
• · Internet/telephone vote revocation cutoff is 11:00 a.m. Eastern Time on November 18, 2026
• · Proposal 5 seeks approval of share issuances tied to convertible notes under an amended and restated Securities Purchase Agreement dated October 9, 2026, a potential source of dilution
• · Proposals 1, 3, 4 and 5 are non-routine, so brokers cannot vote uninstructed shares on them; Proposals 2 and 6 are routine
• · Director election is by plurality; the filing text references three nominees receiving the most votes while the Board recommendation references two director nominees, an internal inconsistency to note

20-10-2026

Giftify, Inc. (GIFT) has filed its DEF 14A proxy statement for a virtual 2026 Annual Meeting of Shareholders on December 18, 2026, asking shareholders to elect five directors and ratify Weinberg & Company, P.A. as independent registered public accounting firm. The filing references the company's FY2025 annual report and describes its two operating businesses: CardCash, a gift card exchange acquired in December 2023, and Restaurant.com, a restaurant deals brand. The filing provides no quantitative period-over-period financial results, so no balanced performance comparison can be drawn from this document.

• · CardCash's four business channels (bulk to bulk, bulk to retail, retail to bulk, retail to retail) are expected to account for an aggregate 50% of sales over the next two years, while bulk-to-bulk remains the largest contributor.
• · Restaurant.com's B2C division generated approximately 15% of FY2025 gross revenue, while B2B generated approximately 85%, indicating heavy concentration in the business-to-business channel.
• · CardCash's 16.8% blended gross margin is a current baseline, and management targets an approximate 8% margin increase over two years, driven by retail-sourced inventory and retail sales.
• · The filing's proposals are routine: a five-director election and auditor ratification, with the Board recommending FOR on both; no contested matters, mergers, or financing proposals are listed.
• · The filing does not provide FY2025 or FY2026 revenue, net income, or other period-over-period financial results, so financial performance cannot be assessed from this document alone.

20-10-2026

Nutanix's DEF 14A proxy statement, dated October 20, 2026, announces the 2026 virtual annual meeting on December 11, 2026 and seeks votes on four proposals: director elections, ratification of Deloitte & Touche LLP for fiscal 2027, an advisory say-on-pay vote, and an increase in the 2016 Equity Incentive Plan share reserve. The accompanying CEO letter reports fiscal 2026 revenue of $2.85 billion (12% YoY growth), ARR of $2.55 billion (16% YoY growth), and record free cash flow of $841 million (29% margin), while noting headwinds from significantly higher hardware pricing and longer partner hardware lead times that affected customer budgets and project timelines.

• · Annual meeting: Friday, December 11, 2026, 9:00 a.m. Pacific Time, virtual only; record date October 13, 2026
• · Four proposals: (1) director election, (2) Deloitte ratification, (3) advisory say-on-pay, (4) increase in 2016 Equity Incentive Plan share reserve; board recommends FOR on all
• · Headwinds cited: significantly increased hardware pricing and longer hardware lead times from partners affected customer budgets and project timelines
• · Fiscal 2026 marked the company's third consecutive year surpassing the Rule of 40
• · Partner agreements signed or enhanced with AMD, Lenovo, NetApp and NVIDIA during the year
• · Expanded external storage support, letting customers keep existing storage investments while modernizing compute and management

20-10-2026

MFS Utilities Fund, a series of MFS Series Trust VI, has filed a definitive proxy statement seeking shareholder approval at a special meeting on December 17, 2026 to reclassify the Fund from diversified to non-diversified under the Investment Company Act of 1940. The Board unanimously recommends a FOR vote, arguing the change gives MFS more flexibility to manage concentrated single-issuer positions; the investment objective, strategy and other investment policies are stated to remain unchanged. As of July 31, 2026, issuers above 5% comprised 30.84% of the Fund's total assets versus 38.97% of the S&P 500 Utilities Index.

• · Record date for voting eligibility is September 24, 2026
• · Votes must be received by Computershare by 1:00 PM Eastern Time on December 17, 2026
• · Fund remains subject to tax diversification requirements under the Internal Revenue Code even if reclassified
• · Fund is not required to sell positions that exceed diversification limits due to market appreciation, but cannot add to them until compliant
• · Proxy solicitation is being run by third-party firm Computershare, which may follow up with shareholders who have not voted

20-10-2026

Mountain Crest Acquisition Corp. V (MCAGU), a SPAC, disclosed a proxy statement for its business combination with CubeBio via a Business Combination Agreement signed August 29, 2024. The company was delisted from Nasdaq in November 2024 after failing to complete a business combination within 36 months of its IPO, and it now trades over-the-counter. Stockholders extended the deadline to complete a combination to November 16, 2026, while heavy redemptions continued, leaving the company's prospects dependent on closing the CubeBio deal before that date.

• · Company was delisted from Nasdaq; Form 25-NSE filed April 11, 2025 removed securities from listing and registration
• · Earnout shares are issuable to CubeBio shareholders only if CubeBio's fiscal 2026 revenue meets the Revenue Threshold; none are issued otherwise
• · If no business combination is completed by November 16, 2026, the company must dissolve and liquidate
• · Prior listing-compliance matters (late 10-K/10-Q filings) were resolved with Nasdaq in 2024 but illustrate ongoing reporting-timeliness history
• · Mountain Crest's sponsor track record includes completed deals with PLBY Group (Playboy), Better Therapeutics, and ETAO International

20-10-2026

MFS Variable Insurance Trust's MFS Utilities Series has filed a definitive proxy statement seeking shareholder approval, at a special meeting on December 17, 2026, to reclassify the Fund from 'diversified' to 'non-diversified' under the Investment Company Act of 1940. MFS and the Board unanimously recommend a FOR vote, arguing the change gives MFS greater flexibility to manage concentrated positions in utilities issuers, while the Fund's investment objective, strategy and other policies remain unchanged. Concentration risk is a stated trade-off the Trustees considered.

• · Record date for voting eligibility is September 24, 2026; the meeting is at 1:00 PM Eastern Time on December 17, 2026, and votes must be received by then
• · Shareholders can vote by telephone (1-866-298-8476), via www.proxy-direct.com, by mailed proxy card, or in person at the meeting
• · Under the 1940 Act, a diversified fund cannot hold more than 5% of total assets in one issuer or more than 10% of an issuer's voting securities (applied to 75% of assets); non-diversified funds are exempt from these limits but remain subject to Internal Revenue Code tax diversification rules
• · Diversification limits apply at purchase; a diversified fund need not sell positions that grow past limits through market appreciation but cannot add to them until compliant
• · The Fund's investment objective (total return), strategy and other investment policies will not change if the reclassification is approved
• · Trustees weighed risks of greater issuer concentration plus costs of proxy solicitation (by Computershare, if needed) and potential portfolio repositioning
• · The Fund is actively managed and does not track Index weightings; post-approval it may hold over- or underweight positions relative to the Index